Evidence map›Paper›PMID 28643772›Full record

ArticleNature communications2017

Cryptic indole hydroxylation by a non-canonical terpenoid cyclase parallels bacterial xenobiotic detoxification.

Susann Kugel, Martin Baunach, Philipp Baer, Mie Ishida-Ito, Srividhya Sundaram, Zhongli Xu, Michael Groll, Christian Hertweck

Abstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Advances in microbial biosynthesis of indirubin.Chinese herbal medicines · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Bacterial terpenome.Natural product reports · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Enzymatic Cascade Reactions in Biosynthesis.Angewandte Chemie (International ed. in English) · 2019
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Susann KugelDepartment of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Beutenbergstr. 11a, 07745 Jena, Germany.
Martin BaunachDepartment of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Beutenbergstr. 11a, 07745 Jena, Germany.
Philipp BaerCenter for Integrated Protein Science Munich (CIPSM), Department Chemie, Technische Universität München, Lichtenbergstr. 4, 85748 Garching, Germany.
Mie Ishida-ItoDepartment of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Beutenbergstr. 11a, 07745 Jena, Germany.
Srividhya SundaramDepartment of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Beutenbergstr. 11a, 07745 Jena, Germany.
Zhongli XuDepartment of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Beutenbergstr. 11a, 07745 Jena, Germany.
Michael GrollCenter for Integrated Protein Science Munich (CIPSM), Department Chemie, Technische Universität München, Lichtenbergstr. 4, 85748 Garching, Germany.
Christian HertweckDepartment of Biomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Beutenbergstr. 11a, 07745 Jena, Germany.ORCID 0000-0002-0367-337X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Terpenoid natural products comprise a wide range of molecular architectures that typically result from C-C bond formations catalysed by classical type I/II terpene cyclases. However, the molecular diversity of biologically active terpenoids is substantially increased by fully unrelated, non-canonical terpenoid cyclases. Their evolutionary origin has remained enigmatic. Here we report the in vitro reconstitution of an unusual flavin-dependent bacterial indoloterpenoid cyclase, XiaF, together with a designated flavoenzyme-reductase (XiaP) that mediates a key step in xiamycin biosynthesis. The crystal structure of XiaF with bound FADH

Indexed as

BacteriaBacterial ProteinsCyclizationFlavin-Adenine DinucleotideHydroxylationInactivation, MetabolicIndigo CarmineIndolesLyasesMolecular StructurePhylogenyTerpenesXenobiotics1,5-dihydro-FADBacterial ProteinsFlavin-Adenine DinucleotideIndigo CarmineindirubinIndolesLyasesTerpenesXenobiotics

Identifiers

PMID28643772
PMCPMC5481743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.